NEOG Stock - Neogen Corporation
Unlock GoAI Insights for NEOG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $894.66M | $924.22M | $822.45M | $527.16M | $468.46M |
| Gross Profit | $421.38M | $462.63M | $405.95M | $243.01M | $215.06M |
| Gross Margin | 47.1% | 50.1% | 49.4% | 46.1% | 45.9% |
| Operating Income | $9.42M | $77.43M | $37.52M | $58.62M | $74.17M |
| Net Income | $-1,092,044,000 | $-9,421,000 | $-22,870,000 | $48.31M | $60.88M |
| Net Margin | -122.1% | -1.0% | -2.8% | 9.2% | 13.0% |
| EPS | $-5.03 | $-0.04 | $-0.12 | $0.45 | $0.57 |
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 29th 2025 | William Blair | Downgrade | Market Perform | - |
| December 19th 2024 | Guggenheim | Initiation | Buy | $15 |
| June 16th 2023 | Wells Fargo | Initiation | Overweight | $22 |
| November 22nd 2022 | William Blair | Upgrade | Outperform | - |
| July 12th 2022 | Piper Sandler | Initiation | Neutral | $25 |
Earnings History & Surprises
NEOGEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 7, 2026 | — | — | — | — |
Q1 2026 | Jan 9, 2026 | $0.08 | — | — | — |
Q4 2025 | Oct 9, 2025 | $-0.07 | $0.04 | +154.1% | ✓ BEAT |
Q3 2025 | Jul 29, 2025 | $0.08 | $0.05 | -37.5% | ✗ MISS |
Q2 2025 | Apr 9, 2025 | $0.13 | $0.10 | -23.1% | ✗ MISS |
Q1 2025 | Jan 10, 2025 | $0.09 | $0.11 | +22.2% | ✓ BEAT |
Q4 2024 | Oct 10, 2024 | $0.09 | $0.07 | -17.6% | ✗ MISS |
Q3 2024 | Jul 30, 2024 | $0.12 | $0.10 | -16.7% | ✗ MISS |
Q2 2024 | Apr 9, 2024 | $0.14 | $0.12 | -14.3% | ✗ MISS |
Q1 2024 | Jan 9, 2024 | $0.15 | $0.11 | -26.7% | ✗ MISS |
Q4 2023 | Oct 10, 2023 | $0.14 | $0.11 | -21.4% | ✗ MISS |
Q3 2023 | Jul 27, 2023 | $0.10 | $0.14 | +40.0% | ✓ BEAT |
Q1 2023 | Mar 30, 2023 | $0.03 | $0.12 | +366.7% | ✓ BEAT |
Q1 2023 | Jan 5, 2023 | $-0.08 | $0.15 | +287.5% | ✓ BEAT |
Q3 2022 | Sep 27, 2022 | $0.16 | $0.15 | -6.3% | ✗ MISS |
Q3 2022 | Jul 26, 2022 | $0.12 | $0.14 | +16.7% | ✓ BEAT |
Q1 2022 | Mar 24, 2022 | $0.15 | $0.13 | -13.3% | ✗ MISS |
Q4 2021 | Dec 21, 2021 | $0.17 | $0.17 | 0.0% | = MET |
Q3 2021 | Sep 21, 2021 | $0.16 | $0.16 | 0.0% | = MET |
Q3 2021 | Jul 20, 2021 | $0.17 | $0.15 | -11.8% | ✗ MISS |
Latest News
Neogen Appoints Bryan Riggsbee CFO, Effective Nov. 3
➖ NeutralPiper Sandler Reiterates Neutral on Neogen, Raises Price Target to $6.5
➖ NeutralNeogen shares are trading higher after the company reported better-than-expected Q1 sales results and issued FY26 sales guidance above estimates.
📈 PositiveNeogen to cut 10% of workforce; shares rise
📈 PositiveNeogen Affirms FY2026 Sales Guidance of $820.000M-$840.000M vs $819.102M Est
📈 PositiveNeogen Q1 Adj. EPS $0.04, Inline, Sales $209.189M Beat $204.160M Estimate
📈 PositiveCJS Securities Initiates Coverage On Neogen with Market Perform Rating, Announces Price Target of $10
➖ NeutralNeogen shares are trading lower after the company announced that the CFO and COO David Naemura plans on resigning.
📉 NegativeNeogen Corporation Announces That CFO And COO David Naemura Plans To Depart The Company. He Will Remain In His Roles Until At Least The Filing Of The Company's 10-Q In October, And No Later Than The End Of 2025.
📉 NegativeNeogen falls after Q4 update
📉 NegativeFrequently Asked Questions about NEOG
What is NEOG's current stock price?
What is the analyst price target for NEOG?
What sector is Neogen Corporation in?
What is NEOG's market cap?
Does NEOG pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to NEOG for comparison